Cargando…
Massive surge of mRNA expression of clonal B-cell receptor in patients with COVID-19
BACKGROUND: Antibody production is one of the primary mechanisms for recovery from coronavirus disease 2019 (COVID-19). It is speculated that massive clonal expansion of B cells, which can produce clinically meaningful neutralizing antibodies, occurs in patients who recover on the timing of acquirin...
Autores principales: | Funakoshi, Yohei, Ohji, Goh, Yakushijin, Kimikazu, Ebisawa, Kei, Arakawa, Yu, Saegusa, Jun, Matsumoto, Hisayuki, Imanishi, Takamitsu, Fukuda, Eriko, Matsutani, Takaji, Mori, Yasuko, Iwata, Kentaro, Minami, Hironobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352648/ https://www.ncbi.nlm.nih.gov/pubmed/34395931 http://dx.doi.org/10.1016/j.heliyon.2021.e07748 |
Ejemplares similares
-
Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur–uracil as postoperative adjuvant chemotherapy
por: Nishikubo, Megumi, et al.
Publicado: (2023) -
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer
por: Funakoshi, Yohei, et al.
Publicado: (2022) -
Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination
por: Funakoshi, Yohei, et al.
Publicado: (2022) -
Regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report
por: Kimbara, Shiro, et al.
Publicado: (2021) -
Increase in Antibody Titers Following Sars-Cov-2 Vaccination Remains Limited for More Than 3 Years after Final Dose of Anti-CD20 Antibody
por: Funakoshi, Yohei, et al.
Publicado: (2021)